Skip to main content

NuGen Signs Marketing Agreements with Asian, European Partners; Opens European Sales Office

NEW YORK, Feb. 2 (GenomeWeb News) - NuGen Technologies has signed agreements with MediBic of Japan and TouchDown Biomarketing in Europe to help it market and sell its RNA-amplification products in Asia and Europe, respectively, the company said yesterday.


San Carlos, Calif.-based NuGen also said it has opened a sales office in Europe, which will be managed by TouchDown. NuGen's European sales team will work with TouchDown to launch the company's RNA-amplification systems in the European market.


MediBic, a Japanese life sciences and pharmacogenomics consulting company, will help NuGen introduce its Ovation RNA-amplification products throughout Asia.


TouchDown is based in Gendt, The Netherlands, and MediBic is located in Tokyo.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.